The effect of adenosine on intraparenchymal cerebral blood flow was examined in conscious rabbits with the 133Xe clearance technique. Perivascular appli cation of 10-3 and 10-4 M adenosine to hypothalamic blood vessels increased hypothalamic blood flow by -50% (p < 0.005). This vasodilatation was attenuated by the intrahypothalamic injection of the �-adrenergic re ceptor antagonist propranolol, but was unaffected by a adrenoreceptor blockade with phenoxybenzamine, or depression of neuronal activity with barbiturate. 2-Chlo roadenosine, a stable analogue of adenosine, also in creased hypothalamic blood flow by 50% (p < 0.005), but this dilatation was unaffected by propranolol. These re-Address correspondence and reprint requests to Dr. Mitchell at
The increase in cerebral blood flow (CBF) pro duced by chemical and electrical stimulation of nerves supplying brain tissue results partly from the release of vasodilator metabolites from neurons (Klugman et ai., 1982) . Hydrogen ions are thought to be one of these metabolites (Klugman et al., 1980) . The purine nucleoside adenosine also con forms to many of the criteria for a metabolic regu lator of cerebral blood flow (Winn et ai., 1981b) . The release of endogenous adenosine parallels the changes in CBF induced by a number of patho physiological stimuli, including ischaemia (Berne et ai., 1974; Winn et ai., 1979b) , hypoxia (Winn et ai., 1979a (Winn et ai., , 1981a , electrical stimulation (Rubio et aI., 1975) , chemically induced seizures (Winn et ai., 1980b) , and reductions in cerebral perfusion pres sure (Winn et ai., 1980a) . Further, adenosine is re leased rapidly from neurons, whereas changes in sults suggest that adenosine increased hypothalamic blood flow at high concentrations by vascular receptor systems dependent on adenosine receptors and adren ergic receptors. Adenosine (10-6 M) reduced hypotha lamic blood flow by -25% (p < 0.005). This vasocon striction was unaffected by adrenergic blockade with pro pranolol or phenoxybenzamine, or by inhibition of neuronal activity with barbiturate. The results suggest that adenosine decreases hypothalamic blood flow at low concentrations by stimulation of adenosine receptors as sociated with vascular smooth muscle. Key Words: Adenosine -Barbiturate -2 -Chloroadenosine -Hypotha -1amic blood flow-Phenoxybenzamine-Propranolol.
hydrogen ion concentration are slow (Winn et ai., 1979b) .
The effects of adenosine on CBF have been studied with pial vessel caliber measurements in cats (Wahl and Kuschinsky, 1976; Forrester et ai., 1979; Gregory et ai., 1980) , and J 33 Xe clearance in baboons (Forrester et ai., 1979) . Other studies have been reviewed by Winn et ai. (1981b) . The effects of perivascular application of adenosine on intra parenchymal cerebral blood vessels has not yet been analysed. We have therefore investigated the effects of adenosine on hypothalamic blood vessels of rabbits with a technique that allows topical in jection of adenosine at the same site in which blood flow is measured.
Cerebral blood vessels (in particular, hypotha lamic blood vessels of rabbits) have a rich adren ergic nerve supply, the fibres of which terminate on or near intraparenchymal blood vessels (Csillik et al., 1971; Hartman et al., 1972) . Since adenosine may regulate neurotransmission (Fredholm and Hedqvist, 1980) , we also investigated whether ef fects of adenosine on cerebral blood flow result from modulation of adrenergic nerves innervating intraparenchymal blood vessels.
METHODS

Animals
We used 55 New Zealand white rabbits of both sexes weighing 2-3 kg.
Measurement of hypothalamic blood flow
Hypothalamic blood flow was measured with the I33Xe clearance technique (Hoedt-Rasmussen et aI., 1966) as modified by Rosendorff (1972) . The hypothalamus was chosen because it is a relatively large region of homoge neously perfused grey matter with an equal, discrete blood supply to each lateral half (Rosendorff, 1972) .
Injection cannulae were placed so that their tips lay in the hypothalamus at stereotaxic coordinates aB on each side of the midline, with the cannulae inserted to a depth of 15 mm (Monnier and Gangloff, 1961) . One side of the hypothalamus was designated the control side and the other the test side. Each was injected alternately at in tervals of 15 min.
The clearance of the radioactive isotope was measured for 500 s after each injection by an external collimated scintillation counter and recorded on magnetic tape with a Hewlett-Packard 2644A video terminal. Hypothalamic blood flow was then calculated from the 133Xe decay curve on an IBM 370/158 computer by nonlinear regres sion analysis (Rosendorff et aI., 1976) . Hypothalamic blood flow (ml/l00 g tissue min-I) was obtained from the formula hypothalamic blood flow (HBF) = x.. 13, where 13 is the decay parameter of the monoexpotential clear ance curve and X. is the tissue-blood partition coefficient for xenon (X. = 0.74 for the rabbit hypothal amus) (Rosendorff and Luff, 1970) .
Multiexponential curves which indicate inaccurate in jections or excessive diffusion or leakage of xenon form -5% of curves obtained with this technique (Mitchell et al. 1975 ). They were not included in analyses. Thus, only steady-state flows, at least during the period of xenon clearance, were used to assess effects of test substances.
The usefulness and limitations of this technique have been carefully assessed elsewhere (Cranston and Rosen dorff , 1971 ). Briefly, it has been shown on light micro scopic examination that there is no disruption of hypo thalamic tissue in rabbits cannulated four times, with mul tiple injections on each occasion. Autoregulation in the hypothalamus was maintained. The effect of the cannu lation procedure, including the possibility that it evokes leakage of neurotransmitters, was controlled by using one-half of the hypothalamus as the control side and the other as the test side. The control side received treatment and injections identical to those of the test side except that test-side injections contained the substance being as sessed.
Experimental protocol
The first series of experiments was designed to show the effects of various concentrations of adenosine (Boeh ringer Mannheim) on hypothalamic blood flow. Adeno sine, at concentrations ranging from 1O-lOto 10-3 M, was �njected together with 133Xe in saline into the test side of the hypothalamus. We also measured the effect of 10-5 M 2-chloroadenosine (Sigma), an adenosine ana- No.4, 1983 logue resistant to adenosine deaminase catabolism (Huang and Daly, 1974) which mimics the effects of aden osine (Huang and Drummond, 1979) .
The second series of experiments was designed to es tablish the possible mechanisms of adenosine-induced va sodilatation and vasoconstriction. We assessed interac tion of adenosine with adrenergic receptors or nerves by using specific a-and !3-adrenoreceptor antagonists. Fifty micrograms of phenoxybenzamine (Dibenyline®, Smith Kline & French) or 20 fLg propranolol (Imperial Chemical Industries) were injected, followed by adenosine and I33Xe-in-saline. We used barbiturate (pentobarbitone so dium; May and Baker) to assess the effect of adenosine on neuronal metabolism. The rationale of these experi ments was that if adenosine changed hypothalamic blood flow indirectly by modulating neuronal activity, then spe cific neuronal depressants would alter the response. Bar biturate was chosen because it has a well-established de pressant effect on neurones (Goodman and Gilman, 1975) , but no effect on axons (Richards, 1972) or blood vessels in vitro (Mitchell et aI., 1978) at the concentra tions used. In these experiments, 60 fLg of barbiturate in a volume of 8 fLl saline was injected into the hypothal amus 30 min before hypothalamic blood flow was mea sured with adenosine in 133Xe-in-saline. Sixty micrograms barbiturate, 20 fLg propranolol, or 50 fLg phenoxybenza mine were also injected alone into the test side of the hypothalamus for control measurements. Fresh solutions of all drugs were made up in saline each day.
To determine whether any systemic changes resulted from central injections of adenosine, we also measured blood pressure, blood gas tensions and pH, and central and peripheral temperatures. An ear central artery was catheterized for blood pressure monitoring and obtaining blood samples. Blood pressure was recorded on a Beckman dynograph using a Statham P23AA strain gauge and a strain gauge coupler. Blood gases and pH were measured on an Instrumentation Laboratory 613 pHI blood gas analyser. Rectal temperatures were monitored with a copper-constantin thermocouple and ear skin tem peratures with a thermistor bead (YSI).
The effects, compared to controls, of each substance were analysed with the paired t test. Statistical analysis of whether blocking agents altered the effect of adenosine was done by a two-way analysis of variance (f test).
RESULTS
Although control and test flows remained con stant in individual rabbits, the analysis of variance revealed interindividual variation in hypothalamic blood flow. The mean control flow for all experi ments was 41. 0 ± 1. 1 mllIOO g tissue min-l (x ± SEM). Despite interindividual variation, the anal ysis of changes in hypothalamic blood flow revealed the following effects of the various drugs and treat ments.
Systemic effects
There were no significant changes in blood pres sure, blood gas tensions or pH, or central or pe ripheral temperatures on injection of adenosine into the hypothalamus. Figure 1 shows that adenosine had concentration dependent effects on hypothalamic blood flow at doses ranging from 10-10 to 10-3 M. At 10-10, 10-8, and 10-5 M, adenosine did not change hypothalam ic blood flow significantly. At micromolar (10-6 M) concentrations, adenosine reduced hypothalamic blood flow by �25% (p < 0.005), whereas at the highest doses investigated (10-4 and 10-3 M) , aden osine significantly increased hypothalamic blood flow, by �50% (p < 0.005). Adenosine was not sol uble in saline at greater concentrations.
Effect of adenosine
Adenosine vasodilatation
Adenosine (10-4 M) was chosen for further in vestigation as it displayed the largest vasodilator response. Figure 2 shows that injection of 60 fLg barbiturate into the test hypothalamus had no sig nificant effect on the response to 10-4 M adenosine. Pretreatment with 20 fLg propranolol attenuated the dilatation (p < 0. 01, f test) , but a significant in crease in hypothalamic blood flow was still ob served (p < 0.05, t test). At 10-5 M, 2-chloro- adenosine increased hypothalamic blood flow to nearly the same degree as did 10-4 M adenosine. However, this vasodilatation was not affected by pretreatment with 20 fLg propranolol. Fifty micro grams of phenoxybenzamine had no effect on the vasodilatation induced by 10-4 M adenosine or 2chloroadenosine (not shown). Figure 3 shows that neither adrenergic receptor blockade with 20 fLg propranolol or 50 fLg phen oxybenzamine, nor inhibition of neuronal metabo lism with 60 fLg barbiturate, had any significant ef fect on the vasoconstriction produced by 10-6 M adenosine.
Adenosine vasoconstriction
Effect of barbiturate, propranolol, and phenoxybenzamine on hypothalamic blood flow Figure 4 shows that 60 fLg barbiturate and 50 fLg phenoxybenzamine had no significant effect on hy pothalamic blood flow when injected alone into the test hypothalamus. Twenty micrograms of prop ran-0101, however, produced a small but significant hy pothalamic vasoconstriction (p < 0.005). 
DISCUSSION
In general, analysis of the effects of putative va soactive substances on local CBF is difficult. Radial diffusion of xenon, trauma, and inherent variation of hypothalamic blood flow with time contribute to the observed scatter between data points. In partic ular, analysis of the effects of adenosine is ham pered by the lack of specific adenosine receptor antagonists. The commonly used xanthine de rivatives, which alter cytoplasmic cyclic-AMP concentrations, are not specific enough to allow meaningful interpretation of data. Further, in tis sues, exogenous adenosine is diluted, rapidly taken up by the cells, phosphorylated to AMP, and catab olised to inosine and hypoxanthine, which are not vasoactive. Thus, concentrations higher than ex pected physiological concentrations have to be in jected to produce effects.
Nevertheless, our data support the idea that adenosine is a metabolic vasodilator of cerebral blood vessels (Winn et ai., 1981b) , as 10-4 M adenosine causes vasodilatation of hypothalamic blood vessels. This adenosine-induced vasodilata tion is undoubtedly less than expected because the effects of adenosine are reduced by the acidic pH of the saline in which it is dissolved (Wahl and Kus chinsky, 1976) . Nevertheless, the vasodilatation seems to depend partly on �-adrenergic receptors. The evidence for this is that propranolol, a �-ad renergic receptor antagonist, which had only a small vasoconstrictor effect on hypothalamic blood flow at the dose used ( Fig. 4) , significantly atten uated the vasodilatation (Fig. 2) . Furthermore, the �-adrenoreceptors appear to be associated with vascular smooth muscle, since barbiturate, which depresses neuronal activity (Goodman and Gilman, 1975) but has no effect on blood vessels (Mitchell et ai., 1978) , hypothalamic blood flow (Fig. 4) , or axons (Richards, 1972) , does not significantly modify the dilator response.
Adenosine is a modulator of noradrenergic neu rotransmission, both peripherally and centrally (Sawynok and Jhamandas, 1976; Su, 1978; Ribeiro, 1979; Fredholm and Hedqvist, 1980) , and has been shown to inhibit prejunctional, and enhance post junctional, adrenergic activity (Hedquist and Fred holm, 1976) . Thus, a �-adrenergic receptor-depen dent increase in hypothalamic blood flow induced by adenosine can occur in two possible ways: either indirectly by stimulation of presynaptic �-adreno receptors to enhance transmitter release (Levitzki, 1981) or by a direct action on postsynaptic �-adre noreceptors to mimic transmitter release. However, there are thought to be no presynaptic �-adrenergic receptors in the central nervous system (Langer, 1977; Starke et ai., 1977) , which suggests that 1O-4M adenosine stimulates postsynaptic �-adre noreceptors to increase hypothalamic blood flow. � Adrenergic receptors have also been shown to sub serve the increase in CBF induced by adenosine in the anaesthetised dog (Tsukada et ai., 1979) but not in the goat (Alborch and Martin, 1979) . Propranolol has no inhibitory action on accumulations of cyclic AMP elicited by adenosine in cultured human as trocytoma cells (Clark et al., 1974) , further sup porting our view that the vasodilatation is due to a direct action on blood vessels and not indirectly to stimulation of neuronal metabolism. Moreover, since in our experiments propranolol did not com pletely abolish vasodilatation, adenosine must have had an effect independent of the presence of l3-ad renergic receptors.
To characterise this response to adenosine fur ther, we used 2-chloroadenosine. This is an aden osine analogue with a high affinity for adenosine receptors. 2-Chloroadenosine 00-5 M) produced a vasodilatation very similar to that of 10 -4 M aden osine (Fig. 2) . However, this vasodilatation was not attenuated by pretreatment of the hypothalamus with 20 fLg propranolol. Although it is conceivable that such concentrations of propranolol may have resulted in a nonspecific propranolol:2-chloro adenosine interaction which resulted in an inactiva tion of the agonist, it is also possible that 2-chloro adenosine does not stimulate l3-adrenergic recep tors. It might also be argued that adenosine-induced vasodilatation may stimulate cyclic-AMP formation by inhibition of the a-adrenergic receptors (Jones, 1981) . We found no evidence for this, since pre treatment of the test hypothalamus with the pre dominantly postsynaptic a-adrenergic antagonist phenoxybenzamine (Constantine and Lebel, 1980) had no effect on the vasodilatation induced by 10 -4 M adenosine.
In contrast to the expected finding that adenosine causes vasodilatation of cerebral blood vessels, our data indicate that adenosine is also a vasocon strictor (Fig. 1) . This vasoconstriction was not blocked by phenoxybenzamine, propranolol, or barbiturate ( Fig. 3) , which suggests that vasocon striction is not dependent on adrenergic mecha nisms or on reduced neuronal metabolism. The data support the idea that low concentrations of adeno sine reduce hypothalamic blood flow by a direct action on adenosine receptors on blood vessels.
In conclusion, the perivascular application of the nucleoside adenosine increased hypothalamic blood flow at high concentrations and decreased it at low concentrations. The vasodilatation seems to be at least partly a result of an interaction between aden osine and l3-adrenoreceptors, whereas the effects of 2-chloroadenosine indicate that vasodilatation may be dependent on specific adenosine receptors. The vasoconstrictor effect appears to be a result of stim ulation of adenosine receptors with nanomolar af finities. We speculate, therefore, that adenosine may exert a vasoconstrictor tone under basal met abolic conditions, which is reversed to a vasodila-tation as release of adenosine increases. Thus, adenosine could be an important autoregulatory metabolite mediating both constriction and dilata tion of blood vessels, at least in the hypothalamus.
